Vitamin D and chronic kidney disease

Area of Science:

• Nephrology
• Endocrinology
• Cardiology

Background:

• Chronic kidney disease (CKD) is a significant public health concern and a major risk factor for premature cardiovascular disease.
• Hypovitaminosis D is prevalent in CKD patients, worsening disease progression and cardiovascular complications.
• Vitamin D deficiency is exacerbated by impaired conversion of 25-(OH)vitamin D to its active form, 1,25-dihydroxyvitamin D, in CKD.

Purpose of the Study:

• To investigate the link between hypovitaminosis D and CKD progression and cardiovascular complications.
• To highlight the importance of addressing vitamin D deficiency in CKD management.
• To emphasize the role of vitamin D in modulating immune, renal, and cardiovascular systems.

Main Methods:

• Reviewing emerging evidence on vitamin D's classical and non-classical functions.
• Assessing the impact of 25-(OH)vitamin D repletion on calcitriol synthesis pathways.
• Analyzing the relevance of findings to health disparities in minority populations.

Main Results:

• Vitamin D deficiency significantly impacts CKD progression and cardiovascular outcomes.
• Adequate repletion of 25-(OH)vitamin D fuels both renal and extra-renal calcitriol synthesis.
• Addressing vitamin D deficiency is crucial for managing both classical and non-classical vitamin D functions.

Conclusions:

• Repleting 25-(OH)vitamin D is essential for improving clinical outcomes in CKD patients.
• Findings are critical for national efforts to reduce health disparities, particularly in minority populations with high rates of CKD and vitamin D deficiency.
• Healthcare providers must implement updated guidelines to combat the vitamin D deficiency epidemic in high-risk groups.